| NCT02177721 | Clinical Benefit and Safety of Raxibacumab in Patients With Symptomatic Inhalational Anthrax in a Mass Exposure Scenario | NOT_YET_RECRUITING | PHASE4 | 2026-05 | 2035-12 | 2035-05 |
| NCT05935917 | Study Evaluating the Bioequivalence of Brincidofovir Form H and Form II Tablets in Healthy Adults | COMPLETED | PHASE1 | 2023-05-30 | 2023-09-27 | 2023-08-14 |
| NCT05377255 | Pharmacokinetics (PK) and Safety of Multiple Doses of Intranasal Naloxone in Healthy Adults | COMPLETED | PHASE1 | 2022-03-28 | 2022-05-10 | 2022-05-10 |
| NCT05194358 | Study of SIAN Nasal Spray in Healthy Adults | COMPLETED | PHASE1 | 2021-12-21 | 2023-10-13 | 2023-09-29 |
| NCT05142306 | A COVID-19 Study to Evaluate Safety and PK of COVID-HIG Administered Through IM, SC, or IV Routes to SARS-CoV-2 Uninfected Adults | COMPLETED | PHASE1 | 2021-12-07 | 2022-05-31 | 2022-03-28 |
| NCT05155319 | Universal Influenza A Vaccine in Healthy Adults | COMPLETED | PHASE1 | 2021-12-01 | 2023-10-10 | 2023-10-10 |
| NCT04661839 | A COVID-19 Study to Evaluate Safety and Pharmacokinetics of COVID-HIGIV Administered in Healthy Adults | COMPLETED | PHASE1 | 2020-12-24 | 2021-07-27 | 2021-07-27 |
| NCT04067011 | Velocity 2: An Anthrax Vaccine and Antibiotics Clinical Study | COMPLETED | PHASE2 | 2019-08-12 | 2020-03-19 | 2020-03-05 |
| NCT03877926 | VELOCITY: An Anthrax Vaccine Clinical Study | COMPLETED | PHASE3 | 2019-03-11 | 2020-08-06 | 2020-08-06 |
| NCT03624946 | Study in Healthy Volunteers Evaluating Safety and Pharmacokinetics of Zika Virus Immune Globulin (ZIKV-IG) | COMPLETED | PHASE1 | 2018-06-27 | 2019-03-06 | 2019-03-06 |
| NCT03315104 | Exploring Safety & Clinical Benefit of Anti-Influenza Immunoglobulin Intravenous in Hospitalized Adults With Influenza A | COMPLETED | PHASE2 | 2017-11-17 | 2019-06-17 | 2019-06-17 |
| NCT03160339 | A Study to Assess the Safety, Pharmacodynamics, and Immunogenicity of PXVX0047 | TERMINATED | PHASE1 | 2017-05-01 | 2017-11-27 | 2017-11-27 |
| NCT02696291 | Safety and Pharmacokinetics of UV-4B Solution Administered Orally as Multiple Ascending Doses to Healthy Subjects | TERMINATED | PHASE1 | 2016-05-27 | 2017-03-02 | 2017-03-02 |
| NCT02443623 | VA-008 ACAM2000® Vaccination of Plasma Donors for the Production of VIGIV | COMPLETED | PHASE4 | 2015-09 | 2021-08 | 2021-07 |
| NCT02771730 | Study to Evaluate the Safety and Immunogenicity of an Oral HIV Vaccine in Healthy, HIV-uninfected Adults | TERMINATED | PHASE1 | 2015-03 | 2017-02 | 2017-02 |
| NCT02339155 | Effect of Raxibacumab on Immunogenicity of Anthrax Vaccine Adsorbed | COMPLETED | PHASE4 | 2015-02-24 | 2017-06-06 | 2017-01-03 |
| NCT02051062 | BT-011 Pharmacokinetics of Botulism Antitoxin Heptavalent in Pediatric Patients | ENROLLING_BY_INVITATION | PHASE4 | 2014-10 | 2027-07-31 | 2027-07-31 |
| NCT02061358 | Study to Determine the Safety, Tolerability and Pharmacokinetics of UV-4B Solution Administered Orally in Healthy Subjects | COMPLETED | PHASE1 | 2014-07 | 2015-09 | 2015-07 |
| NCT01979406 | A Phase 1 Ascending Dose Study to Assess the Safety and Immunogenicity of Adenovirus Anthrax Vector Candidate Vaccines | COMPLETED | PHASE1 | 2013-11 | 2015-09 | 2014-10 |
| NCT01770743 | A Phase 2 Safety and Immunogenicity Study for an Anthrax Vaccine Using 3 Schedules and Two Dose Levels | COMPLETED | PHASE2 | 2013-01 | 2014-12 | 2014-02 |
| NCT01753115 | Ciprofloxacin BioThrax Co-Administration Study | COMPLETED | PHASE2 | 2012-12 | 2013-08 | 2013-08 |
| NCT01491607 | Immunogenicity and Safety Study of a Three-Dose BioThrax® Regimen for Post-Exposure Prophylaxis in Healthy Adults | COMPLETED | PHASE3 | 2011-11 | 2012-05 | 2012-05 |
| NCT01263691 | Safety, Tolerability and Immunogenicity Study of AV7909 Anthrax Vaccine in Healthy Adults | COMPLETED | PHASE1 | 2010-12 | 2012-06 | 2012-05 |
| NCT01158157 | VA-006 Vaccinia Vaccine (ACAM2000) for the Production of VIGIV | COMPLETED | PHASE3 | 2010-09-13 | 2012-02-14 | 2012-02-14 |
| NCT01202695 | Safety and Pharmacokinetics Study of Human Monoclonal Antibody (AVP-21D9) | COMPLETED | PHASE1 | 2010-08 | 2011-06 | 2011-06 |
| NCT01006798 | Safety and Immunogenicity of Replication-Competent Adenovirus 4-vectored Vaccine for Avian Influenza H5N1 | COMPLETED | PHASE1 | 2009-10 | 2011-09 | 2011-09 |
| NCT01311674 | Hepatitis B Virus Antibody Booster Program for the Production of Hepatitis B Immune Globulin (HBIG) | TERMINATED | PHASE3 | 2009-09 | 2011-03-11 | 2011-03-11 |
| NCT00845650 | Safety and Pharmacokinetics Study of Anthrax Immune Globulin Intravenous (AIGIV) | COMPLETED | PHASE1, PHASE2 | 2009-02 | 2010-10 | 2010-10 |
| NCT00679172 | Immunogenicity, Safety and Tolerability of the Typhoid Fever Vaccine Candidate M01ZH09 in Healthy Adults | COMPLETED | PHASE2 | 2008-05 | 2008-12 | 2008-12 |
| NCT00636519 | Botulism Antitoxin Effects on Paralysis Induced by Botulinum Neurotoxins in the EDB Muscle | COMPLETED | PHASE1 | 2008-02 | 2009-10 | 2009-10 |
| NCT00448253 | Safety and Pharmacokinetic Study of Anthrax Immune Globulin Derived From Human Serum | COMPLETED | PHASE1 | 2007-07 | 2008-09 | 2008-08 |
| NCT00893516 | CD4 in Combination With CHOP in Treating Non-cutaneous Peripheral TCell Lymphoma | TERMINATED | PHASE2 | 2007-05 | 2008-12 | 2008-10 |
| NCT00360737 | Safety Study of 7 Botulinum Antitoxin Serotypes Derived From Horses | COMPLETED | PHASE1 | 2006-07 | 2010-04 | 2006-12 |
| NCT00877656 | HuMax-CD4 in Non-Cutaneous T-Cell Lymphoma | COMPLETED | PHASE2, PHASE3 | 2005-08 | 2008-12 | 2006-01 |
| NCT00053495 | Effect of Dose, Safety, Tolerability of a New Smallpox Vaccine in Adults Without Previous Smallpox Vaccination | COMPLETED | PHASE2 | 2003-01 | 2003-11 | 2003-06 |
| NCT00053482 | Dose Study of ACAM2000 Smallpox Vaccine in Previously Vaccinated Adults | COMPLETED | PHASE2 | 2003-01 | 2003-10 | 2003-04 |